Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options

Author:

Khan Suliman12ORCID,Siddique Rabeea12,Shereen Muhammad Adnan3,Ali Ashaq4,Liu Jianbo5,Bai Qian12,Bashir Nadia3,Xue Mengzhou12

Affiliation:

1. Department of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, China

3. State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China

4. Wuhan institute of Virology, Chinese Academy of Sciences, Wuhan, China

5. Department of Respiratory Medicine, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Abstract

The new decade of the 21 st century (2020) started with the emergence of a novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans, and mechanisms associated with the pathogenicity of SARS-CoV-2 are not yet clear, however, its resemblance to SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing-related studies.

Funder

Postdoctoral grant from The Second Affiliated Hospital of Zhengzhou University

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3